Last edition
News about "HER2-Positive Tumours"
Pierre Fabre, Iktos Partner on AI-Driven Oncology Drug Discovery Collaboration
The partnership between Pierre Fabre and Iktos integrates generative AI and automated chemistry to accelerate small-molecule cancer drug development.
HER2-Positive Tumours | 09/01/2026 | By News Bureau
CDSCO approves AstraZeneca's Trastuzumab Deruxtecan for More HER2-Positive Tumours
With this, Trastuzumab Deruxtecan becomes India’s first Antibody Drug Conjugate (ADC) approved for a tumour-agnostic indication.
HER2-Positive Tumours | 04/10/2025 | By Dineshwori | 239
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy